Be a Smart Investor

Tuesday, May 4, 2021

Charles River Labs Boosts FY21 Outlook - Quick Facts

While reporting financial results for the first quarter on Tuesday, Charles River Laboratories International, Inc. (CRL) raised its earnings, adjusted earnings and revenue growth guidance for the full-year 2021, based on stronger-than-expected first quarter financial performance and robust client demand trends for the remainder of the year.

from RTT - Earnings https://ift.tt/3xNgSzh
via IFTTT

Henry Schein Boosts FY21 Adj. EPS Outlook - Quick Facts

While reporting financial results for the first quarter on Tuesday, Henry Schein, Inc. (HSIC) raised its adjusted earnings from continuing operations guidance for the full-year 2021.

from RTT - Earnings https://ift.tt/3xVzcGu
via IFTTT

Zebra Technologies Boosts FY21 Sales Outlook; Guides Q2 Above Estimates - Quick Facts

While reporting financial results for the first quarter on Tuesday, Zebra Technologies Corp. (ZBRA) initiated its adjusted earnings and adjusted net sales growth guidance for the second quarter as well as adjusted net sales growth outlook for the full year 2021.

from RTT - Earnings https://ift.tt/3b3c7rz
via IFTTT

Zimmer Biomet Reinitiates FY21 Outlook - Quick Facts

While reporting financial results for the first quarter on Tuesday, musculoskeletal healthcare firm Zimmer Biomet Holdings Inc. (ZBH) re-initiated its adjusted earnings and revenue growth outlook for the full-year 2021.

from RTT - Earnings https://ift.tt/3nJGlEU
via IFTTT

Estée Lauder Reinitiates FY21 Outlook In Line With Estimates - Quick Facts

While reporting financial results for the third quarter on Monday, Estée Lauder Cos., Inc. (EL) reinstated its earnings and sales growth guidance for the full-year 2021, in line with analysts' estimates.

from RTT - Earnings https://www.rttnews.com/3190693/estée-lauder-reinitiates-fy21-outlook-in-line-with-estimates-quick-facts.aspx?type=ern
via IFTTT

AstraZeneca Stock Up On Strong Q1 Results, Outlook

Shares of AstraZeneca Plc were gaining around 6 percent in London as well as on Nasdaq after the British drug major reported Friday that its first-quarter profit doubled from last year with strong growth in revenues. Revenues from COVID-19 vaccine sales were $275 million, mainly from Europe. The company also reiterated its fiscal 2021 guidance.

from RTT - Earnings https://ift.tt/3nyLFec
via IFTTT

Imperial Oil Swings To Profit In Q1 - Quick Facts

Imperial Oil Ltd. (IMO, IMO.TO) reported Friday a first-quarter net income of C$392 million or C$0.53 per share, compared to a net loss of C$188 million or C$0.25 per share in the prior-year quarter.

from RTT - Earnings https://ift.tt/3eI4szU
via IFTTT